Circulating Angiogenic Cells and Diabetic Vascular Disease

Overview

Información sobre este estudio

This study is being done to determine the roles that several molecules play in the repair of injured cells that line your blood vessels.

Elegibilidad para la participación

Los requisitos de elegibilidad de los participantes incluyen la edad, el sexo, el tipo y el estadio de la enfermedad, y los problemas de salud o tratamientos previos. Las pautas difieren de un estudio a otro e identifican quiénes pueden o no pueden participar. No hay garantía de que cada persona elegible que desee participar en un ensayo se inscribirá. Comunícate con el equipo del estudio para analizar la elegibilidad del estudio y la posible participación.

Inclusion Criteria:

  • Healthy subjects (fasting plasma glucose <100 mg/dL, two-hour glucose during the 75-g OGTT <140 mg/dL, and A1C <5.7%)
  • Non-smokers and non-obese (BMI£28),
  • Males/females (18-45 years old).
  • Candidates will be free of systemic diseases and conditions known to affect vascular or endothelial function (i.e. hypertension, hypercholesterolemia, coronary artery disease, cancer, inflammatory disease, or smoking).
  • T1DM patients will be non-smoker, free of complications (such as retinopathy, nephropathy, neuropathy, coronary heart disease, and hypertension).

Exclusion Criteria: 

  • Candidates will be considered ineligible if they have active infection, trauma, or exposure to any invasive
  • medical procedures within 2 weeks before collecting blood.
  • The subjects who have medications including “over-the-counter” medications within 2 weeks before collecting blood, will also be excluded (diabetic subjects
  • will be treated with prescribed medications only).
  • Subjects will be asked to refrain from caffeine on the day of the study visit and also refrain from alcohol use on the day before the study visit and the day of the visit. 
  • Subjects will also be asked to fast for 8 hours before they come in for the blood draw.
  • All female subjects must
  • have a negative pregnancy test in order to participate in the study. 
  • Subjects who are breast-feeding will be excluded. 

 

Sedes participantes de Mayo Clinic

Los estatus de los estudios cambian con frecuencia. Comunícate con el equipo del estudio para obtener la información más actualizada acerca de la posibilidad de participar.

Sede de Mayo Clinic Estatus

Rochester, Minn.

Investigador principal de Mayo Clinic

Zvonimir Katusic, M.D., Ph.D.

Cerrado para la inscripción

More information

Publicaciones

Publications are currently not available
.
CLS-20311155

Mayo Clinic Footer